Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis
Authors:
- Stuart M. RobinsonStuart M. Robinson
- Colin H. WilsonCWColin H. Wilson
- Alastair D. BurtAlastair D. Burt
- Derek M. ManasDMDerek M. Manas
Open Access
- 6 July 2012
- journal article
- review article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (13) , 4287-4299
Abstract
Chemotherapy-associated liver injury is a major cause for concern when treating patients with colorectal liver metastases. The aim of this review was to deKeywords
This publication has 83 references indexed in Scilit:
- Estimates of cancer incidence and mortality in Europe in 2008European Journal of Cancer, 2010
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Safe liver resection following chemotherapy for colorectal metastases is a matter of timingBritish Journal of Cancer, 2007
- Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastasesBritish Journal of Surgery, 2007
- Preoperative Chemotherapy and the Outcome of Liver Resection for Colorectal MetastasesWorld Journal of Surgery, 2007
- Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastasesBritish Journal of Surgery, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] MetastasesAnnals of Surgical Oncology, 2001
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986